Detection and characterisation of liver metastases.

Modern liver imaging of cancer patients requires an imaging modality that is not only highly sensitive in detecting lesions but also provides reliable characterisation of lesions and thus allows differentiation of metastases from frequently found benign lesions. Conventional ultrasound (US) has a relatively poor sensitivity and specificity for imaging liver metastases and US used to be inferior to CT and MRI mainly due to a lack of contrast agents. This has changed with the advent of microbubble contrast agents for US. The use of recent contrast agents such as SonoVue (Bracco, Italy) combined with low mechanical index contrast-specific imaging techniques such as Contrast Pulse Sequencing provides dynamic real time imaging of focal liver lesions in the arterial, portal venous and delayed phase. This improves lesion detection and characterisation. To investigate the benefit of SonoVue for detecting liver metastases we studied 40 cancer patients with liver lesions on reference imaging (CT or MRI), 37 of them had metastases. The mean number of reference confirmed metastases per patient increased from 1.85+/-1.79 on conventional ultrasound to 2.73+/-2.50 post SonoVue (p < 0.05). CEUS showed more individual metastases than baseline in 12 (34%) patients. Using CT or MRI as the reference, the mean sensitivity to individual metastases increased from 69% on baseline US to 90% post contrast (p < 0.0005). The role of SonoVue in characterisation of focal liver lesions was evaluated in 63 patients. One lesion was studied per patient. Based on standardised dynamic enhancement criteria for each lesion type, the number of correctly diagnosed lesions improved from 41 (65%) on baseline US to 58 (92%) post contrast (p < 0.001). On CEUS all 27 metastases were correctly diagnosed, while baseline US misinterpreted 2 of these. The number of correctly diagnosed benign lesions (n = 28) increased from 12 (43%) on baseline to 25 (89%) post SonoVue. In conclusion, detection and characterisation of focal liver lesions by US are markedly improved by the use of SonoVue. Contrast agents add a new dimension to sonography allowing it to rival CT and MRI, especially for lesion characterisation.

[1]  T. Ravikumar,et al.  Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors , 1989, Surgery.

[2]  Eckhart Hahn,et al.  Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography for the characterization of focal liver lesions , 2002, International Journal of Colorectal Disease.

[3]  Thomas Albrecht,et al.  Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. , 2003, Radiology.

[4]  Emilio Quaia,et al.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. , 2004, Radiology.

[5]  R. Puls,et al.  [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue]. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[6]  P. Robinson,et al.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. , 1999, Radiology.

[7]  P. Karhunen.  Benign hepatic tumours and tumour like conditions in men. , 1986, Journal of clinical pathology.

[8]  C. Fellbaum,et al.  LIVER Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508 A , 2004 .

[9]  K J Wolf,et al.  Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. , 2001, AJR. American journal of roentgenology.

[10]  K. Tranberg,et al.  Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. , 1993, The European journal of surgery = Acta chirurgica.

[11]  K J Wolf,et al.  Detection of Hepatic Metastases with low MI Real Time Contrast Enhanced Sonography and SonoVue® , 2005, Ultraschall in der Medizin.

[12]  J. Bilbao,et al.  Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[13]  E. Hahn,et al.  [Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents]. , 2003, Ultraschall in der Medizin.

[14]  H. Saeger,et al.  [Detection of liver lesions by contrast-enhanced ultrasound -- comparison to intraoperative findings]. , 2005, Ultraschall in der Medizin.

[15]  M. Reiser,et al.  Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. , 1991, AJR. American journal of roentgenology.

[16]  R C Nelson,et al.  The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. , 1992, AJR. American journal of roentgenology.

[17]  J. Figueras,et al.  Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. , 2001, Radiology.

[18]  H. Schild,et al.  Häufigkeit und Bedeutung von kleinen fokalen Leberläsionen in der MRT , 2001 .

[19]  P. Robinson,et al.  Hepatic lesion detection at MR imaging: a comparative study with four sequences. , 1997, Radiology.

[20]  L Solbiati,et al.  Guidelines for the use of contrast agents in ultrasound. January 2004. , 2004, Ultraschall in der Medizin.

[21]  K. Ishak,et al.  Benign tumors of the liver. , 1975, The Medical clinics of North America.